In a patient with low hemoglobin, low hematocrit, and low red blood cell count but normal ferritin, should an iron infusion be recommended?

Normal Ferritin Does Not Rule Out Iron Deficiency—Additional Testing Required Before Deciding on Iron Infusion

In a patient with anemia (low hemoglobin, hematocrit, and RBC count) but normal ferritin, iron infusion may still be indicated, but you must first measure transferrin saturation (TSAT) and assess for inflammation before making this decision.

Critical Diagnostic Algorithm

The key issue is that ferritin is an acute phase reactant and can appear falsely normal or elevated in the presence of inflammation, chronic disease, or infection, even when true iron deficiency exists 1, 2. You cannot rely on ferritin alone.

Step 1: Measure TSAT and Assess Inflammatory Status

• Order TSAT immediately (serum iron ÷ TIBC × 100)
• Check inflammatory markers: CRP, ESR
• Review clinical context: chronic kidney disease, inflammatory bowel disease, heart failure, malignancy, infection

Step 2: Interpret Results Based on Inflammation Status

Without inflammation (normal CRP/ESR):

• Ferritin <30 μg/L = absolute iron deficiency 1
• TSAT <16% = iron deficiency 1, 2
• If ferritin is truly normal (>30 μg/L) AND TSAT >20%, iron deficiency is unlikely—look for other causes of anemia

With inflammation present:

• The ferritin threshold increases to 100 μg/L 1
• Ferritin 30-100 μg/L + TSAT <16% = likely combined iron deficiency and anemia of chronic disease 1
• Ferritin >100 μg/L + TSAT <16% = anemia of chronic disease predominates 1
• Even with ferritin 100-700 ng/mL, functional iron deficiency can exist if TSAT <20% 2

Step 3: Decision on Iron Infusion

Iron infusion IS recommended when:

• TSAT <20% regardless of ferritin level (indicates functional iron deficiency) 2
• Ferritin <100 μg/L in presence of inflammation 1
• Patient on erythropoiesis-stimulating agents (ESAs) with TSAT <20% 2
• Patient on hemodialysis 2

Iron infusion may NOT be needed when:

• TSAT >20% AND ferritin >100 μg/L without inflammation
• Consider trial of oral iron first if not on dialysis and not receiving ESAs 3

Special Populations

Chronic Kidney Disease patients: Even with ferritin up to 500-1200 ng/mL, if TSAT <25%, IV iron can still improve hemoglobin 4. The DRIVE study demonstrated hemoglobin increases of 16 g/L with IV iron in patients with ferritin 500-1200 ng/mL but low TSAT 4.

Inflammatory conditions (IBD, chronic disease): Ferritin cutoff for iron deficiency increases to 100 μg/L 1. A trial of IV iron (50-125 mg weekly for 8-10 doses) can distinguish functional iron deficiency from inflammatory block 2.

Common Pitfalls to Avoid

1. Never rely on ferritin alone—it misses functional iron deficiency 2
2. Don't assume normal ferritin means adequate iron in inflammatory states 1
3. Don't check iron parameters within 4 weeks of IV iron administration—circulating iron interferes with assays 5
4. Consider newer markers if available: reticulocyte hemoglobin content (CHr), percentage hypochromic RBCs—these are more sensitive for functional iron deficiency than ferritin 3, 6, 7

Monitoring Response

If you proceed with IV iron:

• Expect hemoglobin increase of 1-2 g/dL within 4-8 weeks 5
• Recheck CBC and iron parameters 4-8 weeks after last infusion 5
• If no response after 8-10 doses, suspect inflammatory block rather than iron deficiency 2

The bottom line: Normal ferritin does not exclude the need for iron infusion—TSAT <20% is the critical threshold that indicates iron-restricted erythropoiesis requiring IV iron, even when ferritin appears adequate 2, 4.